Established in 2009, Intelligent Fingerprinting is a spin-out company of UEA with intellectual property in the field of co-detection of identity and illicit substances. The company is developing technology for the high sensitivity and high definition detection of metabolites and fingerprints using proprietary detection reagents and standardised protocols which can be easily deployed into forensics laboratories and for ‘scene of incident’ analysis in policing and homeland security.
The vision of Intelligent Fingerprinting lies in its identification and development of robust, specific, high sensitivity assays for key metabolites present in fingerprints. The company plans to partner with leading global CSI centres of excellence for the testing and validation of its new technology and with leading CSI and security technology suppliers in the distribution of its products; thereby ensuring critical evaluation of its products and the greatest global access for its customers.
Over time Intelligent Fingerprinting will make available through its partners, unique, leading edge immunoassay technology for detection of major classes of illicit substances in fingerprints. The company intends to expand this capability to related technologies based on its research and international collaborations. For more details please contact us.
Intelligent Fingerprinting was founded in 2009 by Professor David Russell, Professor of Chemistry at UEA and Dr Sue Jickells, based on technology developed jointly at UEA and Kings College, London. David and Sue were joined in early 2009 by Dr. Jerry Walker as CEO. Dr. John Polden of ICENI joined the board as non-executive Chairman in October 2009.
Prof. David Russell, Founder and CSO, joined UEA as a lecturer is 1991. He was promoted to a Chair in Chemistry in 2002. His research is focused on the development of analytical diagnostics combining biological recognition molecules with nanoscale devices for selective targeting and measurement. Prof Russell has raised in excess of £5M in research grants (mainly from Research Councils, Charities and Industry) to support his research. He has published >80 primary research papers. He is a current member of the EPSRC College; has been recently part of the RCUK Basic Technology Strategic Advisory Team (2005 - 2008) and is currently on the International editorial advisory board of the Royal Society of Chemistry journal The Analyst. Russell’s research has been recognised through the award of the Royal Society of Chemistry SAC Silver Medal and a Stichting Research Prize from Schlumberger.
Dr Jerry Walker, CEO, has over 24 years experience in Life Sciences commercialization, instrumentation and product development, holding international P&L responsibilities for businesses in informatics, instrument service and more recently CEO of early stage diagnostics businesses including nearly 20 years with Amersham plc and GE Healthcare, Akubio, Lab21 and Oxford MediStress Ltd. Acting as a life sciences consultant Jerry has successfully advised many early stage businesses on broad aspects of their operations from sales and marketing strategies to fund raising, product development, branding and strategic business development.
Dr Paul Yates, Business Development Manager, has over seventeen years’ experience working within the UK Criminal Justice System (CJS); firstly as an Expert Witness Forensic Scientist for the Metropolitan Police Forensic Science Laboratory, and latterly as the Key Customer Account Manager for the Forensic Science Service (FSS) Huntingdon Laboratory. During his time with the FSS, Paul was responsible for business development and account management for all police force customers within the East Anglian region, and worked with partner agencies from across the CJS to maintain and improve the forensic services provided by the FSS Huntingdon Laboratory. Paul’s work included development of services to tackle major crime and sexual assault, and was recognised in 2009 through the presentation of The High Sheriff of Cambridgeshire’s Award for Excellence in Forensic Science.